ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone (RECLAIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00947895
Recruitment Status : Terminated (Study reached halfway point in approximately one year time period and was halted to analyze data.)
First Posted : July 28, 2009
Last Update Posted : March 22, 2016
Sponsor:
Collaborator:
Mallinckrodt
Information provided by (Responsible Party):
Neurologique Foundation, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2011
  Actual Study Completion Date : January 2011